The Lived Experiences Measured Using Rings Pilot Study (LEMURS-P)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Vermont
-
Burlington, Vermont, United States, 05405
- University of Vermont
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Current undergraduate student in their first year of school
- own a mobile device
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: group-based therapy
Group therapy delivered via moodlifters
|
Mood Lifters, a novel mental wellness program, was developed as a more accessible means to provide psychotherapy (Votta & Deldin, 2022).
Meetings covered biopsychosocial areas and skills that were drawn from multiple therapeutic interventions consistent with a biopsychosocial framework.
Areas included physical health, negative thoughts, problem-solving, emotional awareness and regulation, building relationships, behavioral activation, and using a strengths-based approach.
ML is delivered by peer leaders who are individuals that have completed the program as well as a training program.
|
|
Experimental: physical activity
Physical Activity and Exercise
|
Participants randomized to the exercise arm received 14 weeks of a structured weekly strength and conditioning training program to enhance muscle mass, strength, cardiorespiratory fitness, and overall well-being.
The program is based on previous research showing that cardiorespiratory fitness and muscle strength/size can both contribute to decreased mortality/increased longevity and enhanced mental health (Burke et al., 2017; McLeod et al., 2016; Srikanthan & Karlamangla, 2014; Strasser & Burtscher, 2018).
The training program consists of three training sessions per week, with one being an in-person group session guided by a certified strength and conditioning specialist.
The other two training sessions are self-guided via the mobile app Trainheroic.
This weekly training schedule aligns with previous research showing benefits to structuring an exercise program using a variety of social contexts (group setting, own, etc.; Burke et al., 2017).
|
|
Experimental: nature experience
Nature Experiences
|
Participants randomized to the Nature Experiences participated in 14 weeks of group and self-directed activities to connect with the natural environment.
Weekly group activities will be led by Nature Guides, who are undergraduate and graduate students with extensive outdoor education training.
Group activities will last one hour a week and include hiking in forests, walking in parks, bird-watching, mindfulness exercises, and snow activities.
Participants will be given a list of self-directed activity suggestions each week.
The goal of self-directed activities is to spend an additional two hours in a natural environment each week.
|
|
No Intervention: self-monitoring
Placebo control
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression as measured by Depression, Anxiety, Stress Survey - 21 (Depression subscale)
Time Frame: Change in depression scores from time of randomization through 5 months
|
Self Reported Depression
|
Change in depression scores from time of randomization through 5 months
|
|
Anxiety as measured by Depression, Anxiety, Stress Survey - 21 (Anxiety subscale)
Time Frame: Change in anxiety scores from time of randomization through 5 months
|
Self ReportedAnxiety
|
Change in anxiety scores from time of randomization through 5 months
|
|
Stress as measured by Depression, Anxiety, Stress Survey - 21 (Stress subscale)
Time Frame: Change in stress scores from time of randomization through 5 months
|
Self Reported Stress
|
Change in stress scores from time of randomization through 5 months
|
|
Well-Being as measured by Warwick-Edinburgh Mental Well-being Scale
Time Frame: Change in well-being scores from time of randomization through 5 months
|
Self Reported well-being
|
Change in well-being scores from time of randomization through 5 months
|
|
Stress as measured by the Perceived Stress Scale
Time Frame: Change in stress scores from time of randomization through 5 months
|
Self Reported subclinical stress
|
Change in stress scores from time of randomization through 5 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Quality Index
Time Frame: Change in sleep quality scores from time of randomization through 5 months
|
Self Reported Sleep
|
Change in sleep quality scores from time of randomization through 5 months
|
|
Oura Ring Sleep Index
Time Frame: Change in Oura Sleep measured scores from time of randomization through 5 months
|
Biometric Sleep recorded from an Oura Ring
|
Change in Oura Sleep measured scores from time of randomization through 5 months
|
|
Medical Outcomes Social Support Survey
Time Frame: Change in social support scores scores from time of randomization through 5 months
|
Social Support
|
Change in social support scores scores from time of randomization through 5 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Laura Bloomfield, MD, PhD, University of Vermont
- Principal Investigator: Chris Danforth, PhD, University of Vermont
- Principal Investigator: Ryan McGinnis, PhD, University of Vermont
- Principal Investigator: Ellen McGinnis, PhD, University of Vermont
- Principal Investigator: Matthew Price, PhD, University of Vermont
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- LEMURS S23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.